Ellington Management Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-20,000
| Closed | -$149K | – | 973 |
|
|
2018
Q1 | $149K | Buy |
+20,000
| New | +$149K | 0.01% | 749 |
|
|
2017
Q1 | – | Sell |
-13,000
| Closed | -$112K | – | 929 |
|
|
2016
Q4 | $112K | Sell |
13,000
-54,200
| -81% | -$467K | 0.02% | 480 |
|
|
2016
Q3 | $425K | Buy |
+67,200
| New | +$425K | 0.12% | 336 |
|
|
2015
Q4 | – | Sell |
-20,146
| Closed | -$115K | – | 908 |
|
|
2015
Q3 | $115K | Buy |
+20,146
| New | +$115K | 0.03% | 650 |
|
|
2015
Q2 | – | Sell |
-64,400
| Closed | -$385K | – | 970 |
|
|
2015
Q1 | $385K | Buy |
64,400
+11,800
| +22% | +$70.5K | 0.08% | 378 |
|
|
2014
Q4 | $398K | Buy |
+52,600
| New | +$398K | 0.13% | 255 |
|